On Invalid Date, Hcw Biologics (NASDAQ: HCWB) reported Q4 2023 earnings per share (EPS) of -$0.30, up 87.5% year over year. Total Hcw Biologics earnings for the quarter were -$10.68 million. In the same quarter last year, Hcw Biologics's earnings per share (EPS) was -$0.16.
As of Q2 2024, Hcw Biologics's earnings has grown year over year. Hcw Biologics's earnings in the past year totalled -$24.99 million.
What is HCWB's earnings date?
Hcw Biologics's earnings date is Invalid Date. Add HCWB to your watchlist to be reminded of HCWB's next earnings announcement.
What was HCWB's revenue last quarter?
On Invalid Date, Hcw Biologics (NASDAQ: HCWB) reported Q4 2023 revenue of $252.65 thousand up 5.84% year over year. In the same quarter last year, Hcw Biologics's revenue was $268.30 thousand.
What was HCWB's revenue growth in the past year?
As of Q2 2024, Hcw Biologics's revenue has grown -78.33% year over year. This is 224.07 percentage points lower than the US Biotechnology industry revenue growth rate of 145.73%. Hcw Biologics's revenue in the past year totalled $560.36 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.